Your browser doesn't support javascript.
loading
Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo.
Kohs, Tia C L; Olson, Sven R; Pang, Jiaqing; Jordan, Kelley R; Zheng, Tony J; Xie, Aris; Hodovan, James; Muller, Matthew; McArthur, Carrie; Johnson, Jennifer; Sousa, Bárbara B; Wallisch, Michael; Kievit, Paul; Aslan, Joseph E; Seixas, João D; Bernardes, Gonçalo J L; Hinds, Monica T; Lindner, Jonathan R; McCarty, Owen J T; Puy, Cristina; Shatzel, Joseph J.
Afiliación
  • Kohs TCL; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Olson SR; Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR USA.
  • Pang J; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Jordan KR; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Zheng TJ; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Xie A; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR USA.
  • Hodovan J; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR USA.
  • Muller M; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR USA.
  • McArthur C; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR USA.
  • Johnson J; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Sousa BB; Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
  • Wallisch M; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Kievit P; Aronora, Inc., Portland, OR USA.
  • Aslan JE; Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR USA.
  • Seixas JD; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Bernardes GJL; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR USA.
  • Hinds MT; Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
  • Lindner JR; Instituto de Medicina Molecular, João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
  • McCarty OJT; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
  • Puy C; Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239 USA.
  • Shatzel JJ; Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR USA.
Cell Mol Bioeng ; 15(3): 231-243, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35611166
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Mol Bioeng Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cell Mol Bioeng Año: 2022 Tipo del documento: Article